Items where Author is "Antel, J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2011 | 2010 | 2009 | 2008
Number of items: 4.


Mehling, M. and Johnson, T. A. and Antel, J. and Kappos, L. and Bar-Or, A.. (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology, Vol. 76, H. 8, Suppl. 3 , S20-S27.


Comi, G. and O'Connor, P. and Montalban, X. and Antel, J. and Radue, E.-W. and Karlsson, G. and Pohlmann, H. and Aradhye, S. and Kappos, L.. (2010) Phase II study of oral fingolimod (FTY720) in multiple sclerosis : 3-year results. Multiple Sclerosis Journal, 16 (2). pp. 197-207.


O'Connor, P. and Comi, G. and Montalban, X. and Antel, J. and Radue, E. W. and de Vera, A. and Pohlmann, H. and Kappos, L.. (2009) Oral fingolimod (FTY720) in multiple sclerosis : two-year results of a phase II extension study. Neurology : journal of the American Academy of Neurology, Vol. 72. S. 73-79.


Mehling, M. and Brinkmann, V. and Antel, J. and Bar-Or, A. and Goebels, N. and Vedrine, C. and Kristofic, C. and Kuhle, J. and Lindberg, R. L. and Kappos, L.. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology, Vol. 71, H. 16. S. 1261-1267.

This list was generated on Thu Mar 22 09:19:03 2018 CET.